Billing and Coding: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer (A57329) - R5 - Effective February 24, 2022

Date Posted: October 2, 2025

This Billing and Coding Article has been revised under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Effective Date: February 24, 2022

Summary of Changes:

Updated Article Text, second paragraph to correct "The following test are covered in accordance with the LCD: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer." to "The following tests are covered in accordance with the LCD: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer."

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.

Last Updated Oct 02 , 2025